Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study.

Ola Kally Magnusdottir, Rikard Landberg, Ingibjorg Gunnarsdottir, Lieselotte Cloetens, Björn Åkesson, Fredrik Rosqvist, Ursula Schwab, Karl-Heinz Herzig, Janne Hukkanen, Markku J Savolainen, Lea Brader, Kjeld Hermansen, Marjukka Kolehmainen, Kaisa Poutanen, Matti Uusitupa, Ulf Risérus, Inga Thorsdottir

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskriftPeer review

Sammanfattning

Few studies have explored the possible plasma cholesterol lowering effects of rye consumption. The aim of this secondary analysis in the SYSDIET study was to investigate the association between plasma alkylresorcinols (AR), a biomarker for whole grain wheat and rye intake, and blood lipid concentrations in a population with metabolic syndrome. Furthermore, we analyzed the associations between the AR C17∶0/C21∶0 ratio, a suggested marker of the relative intake of whole grain/bran rye, and blood lipid concentrations.
Originalspråkengelska
Artikelnummere110827
TidskriftPLoS ONE
Volym9
Nummer10
DOI
StatusPublished - 2014

Ämnesklassifikation (UKÄ)

  • Biokemi och molekylärbiologi

Fingeravtryck

Utforska forskningsämnen för ”Whole grain rye intake, reflected by a biomarker, is associated with favorable blood lipid outcomes in subjects with the metabolic syndrome - a randomized study.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här